Diffuse expression of RNA-binding protein IMP3 predicts high-stage lymph node metastasis and poor prognosis in colorectal adenocarcinoma

Annals of Surgical Oncology

Volumn 16, Issue 6, 2009, Pages 1711-1719

  Yuan, Ray Hwang ^a,b,c   Wang, Chi Chao ^a   Chou, Chia Cheng ^a   Chang, King Jen ^b,c   Lee, Po Huang ^b,c   Jeng, Yung Ming ^b,c  

^a TAO YUAN GENERAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN IMP3; RNA BINDING PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CELL GROWTH; CELL MIGRATION; COLORECTAL CARCINOMA; EMBRYO DEVELOPMENT; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; TUMOR GROWTH;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; RNA-BINDING PROTEINS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 67349132840     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0446-0     Document Type: Article

References (37)

1. I Zlobec A Lugli 2008 Prognostic and predictive factors in colorectal cancer J Clin Pathol 61 561 569
2. JT Liang YM Cheng KJ Chang CT Chien HC Hsu 1999 Reappraisal of K-ras and p53 gene mutations in the recurrence of Dukes' B2 rectal cancer after curative resection Hepatogastroenterology 46 830 837 (Pubitemid 29224748)
3. J Folkman 1990 What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82 4 6 (Pubitemid 20020880)
4. CE Eberhart RJ Coffey A Radhika 1994 Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas Gastroenterology 107 1183 1188 (Pubitemid 24294584)
5. T Wang L Fan Y Watanabe 2003 L523S, an RNAbinding protein as a potential therapeutic target for lung cancer Br J Cancer 88 887 894 (Pubitemid 36520876)
6. RK Yantiss BA Woda GR Fanger 2005 KOC (Komology Domain Containing Protein Overexpressed in Cancer): a novel molecular marker that distinguishes between benign and malignant lesions of the pancreas Am J Surg Pathol 29 188 195 (Pubitemid 40170636)
7. J Nielsen J Christiansen J Lykke-Andersen 1999 A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development Mol Cell Biol 19 1262 1270 (Pubitemid 29046868)
8. F Mueller-Pillasch B Pohl M Wilda 1999 Expression of the highly conserved RNA binding protein KOC in embryogenesis Mech Dev 88 95 99 (Pubitemid 29467415)
9. C Li KL Rock BA Woda 2007 IMP3 is a novel biomarker for adenocarcinoma in situ of the uterine cervix: an immunohistochemical study in comparison with p16(INK4a) expression Mod Pathol 20 242 247 (Pubitemid 46422179)
10. TM Gress F Muller-Pillasch M Geng 1996 A pancreatic cancer-specific expression profile Oncogene 13 1819 1930 (Pubitemid 26377516)
11. T Wang D Hopkins C Schmidt 2000 Identification of genes differentially over-expressed in lung squamous cell carcinoma using combination of cDNA subtraction and microarray analysis Oncogene 19 1519 1528 (Pubitemid 30175673)
12. Z Jiang P Chu BA Woda 2006 Analysis of RNA binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study Lancet Oncol 7 556 564 (Pubitemid 43923666)
13. NE Hoffmann Y Sheinin CM Lohse 2008 External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma Cancer 112 1471 1479
14. W Zheng X Yi O Fadare 2008 The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma Am J Surg Pathol 32 304 315
15. L Sitnikova G Mendese Q Liu 2008 IMP3 predicts aggressive superficial urothelial carcinoma of the bladder Clin Cancer Res 14 1701 1706
16. YM Jeng CC Chang FC Hu 2008 Expression of RNA-binding protein IMP-3 promotes tumor invasion and predicts high tumor stage, early tumor recurrence, and poor prognosis in hepatocellular carcinoma Hepatology 48 1118 1127
17. F Mueller-Pillasch U Lacher C Wallrapp 1997 Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein Oncogene 14 2729 2733 (Pubitemid 27283112)
18. B Liao Y Hu DJ Herrick G Brewer 2005 The RNA-binding protein IMP-3 is a translational activator of insulin-like growth factor II leader-3 mRNA during proliferation of human K562 leukemia cells J Biol Chem 280 18517 18524 (Pubitemid 41389102)
19. JB O'Connell MA Maggard CY Ko 2004 Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging J Natl Cancer Inst 96 1420 1425 (Pubitemid 39429665)
20. J Wang JM Hassett MT Dayton MN Kulaylat 2008 Lymph node ratio: role in the staging of node-positive colon cancer Ann Surg Oncol 15 1600 1608
21. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual. 6th ed. New York: Springer-Verlag, 2002.
22. H Nelson N Petrelli A Carlin 2001 Guidelines 2000 for colon and rectal cancer surgery J Natl Cancer Inst 93 583 596 (Pubitemid 32409626)
23. JE Tepper MJ O'Connell D Niedzwiecki 2001 Impact of number of nodes retrieved on outcome in patients with rectal cancer J Clin Oncol 19 157 163 (Pubitemid 32063492)
24. TE Le Voyer ER Sigurdson AL Hanlon 2003 Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089 J Clin Oncol 21 2912 2919 (Pubitemid 46621841)
25. AC Berger ER Sigurdson T LeVoyer 2005 Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes J Clin Oncol 23 8706 8712 (Pubitemid 46211514)
26. SH Telian AJ Bilchik 2008 Significance of the lymph node ratio in stage III colon cancer Ann Surg Oncol 15 1557 1558
27. LJ Megale Costa HP Soares HA Gaspar 2004 Ratio between positive lymph nodes and total dissected axillaries lymph nodes as an independent prognostic factor for disease-free survival in patients with breast cancer Am J Clin Oncol 27 304 306 (Pubitemid 38737808)
28. WA Woodward V Vinh-Hung NT Ueno 2006 Prognostic value of nodal ratios in node-positive breast cancer J Clin Oncol 24 2910 2916 (Pubitemid 46630594)
29. JR Siewert K Böttcher HJ Stein JD Roder 1998 Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study Ann Surg 228 449 461 (Pubitemid 30194389)
30. K Inoue Y Nakane H Iiyama 2002 The superiority of ratio-based lymph node staging in gastric carcinoma Ann Surg Oncol 9 27 34 (Pubitemid 34262894)
31. MB Slidell DC Chang JL Cameron 2008 Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis Ann Surg Oncol 15 165 174
32. P Schumacher S Dineen C Barnett Jr JTA Fleming 2007 The metastatic lymph node ratio predicts survival in colon cancer Am J Surg Pathol 194 827 831 (Pubitemid 350086537)
33. HY Lee HJ Choi KJ Park 2007 Prognostic significance of metastatic lymph node ratio in node-positive colon carcinoma Ann Surg Oncol 14 1712 1717 (Pubitemid 46791006)
34. YM Jeng TH Wang SH Lu RH Yuan HC Hsu 2008 Prognostic significance of insulin-like growth factor II mRNA-binding protein 3 expression in gastric adenocarcinoma Br J Surg 96 66 73
35. De Ridder M, Vinh-Hung V, Van Nieuwenhove Y, et al. Prognostic value of the lymph node ratio in node positive colon cancer. Gut. 2006;55:1681. (Pubitemid 44629243)
36. J Vikesaa TV Hansen L Jonson 2006 RNA-binding IMPs promote cell adhesion and invadopodia formation EMBO J 25 1456 1468
37. K Yaniv A Fainsod C Kalcheim JK Yisraeli 2003 The RNA-binding protein Vg1 RBP is required for cell migration during early neural development Development 130 5649 5661 (Pubitemid 37540841)